New AI Model Predicts Acral Melanoma Metastasis Risk
A new predictive model for acral melanoma may help clinicians more accurately identify the risk of lymph node spread.
Updated on Oct. 26, 2026 in Cancer
Live Poll
Do you trust diagnostic models developed by artificial intelligence as much as human medical experts?
Researchers have developed a new machine learning model capable of predicting lymph node metastasis in patients with acral melanoma. This tool could improve early detection for individuals facing this aggressive skin cancer.
Why it matters
Acral melanoma is often diagnosed at later stages, making the accurate assessment of regional lymph node spread a significant clinical challenge. This new model offers a more precise method for evaluating risk, potentially guiding more timely treatment decisions.
In a retrospective study of 189 patients, the gradient boosting model achieved an area under the curve (AUC) of 0.868, demonstrating superior diagnostic performance compared to traditional clinical models. Sensitivity was 0.889 and specificity was 0.733 in the internal validation cohort.
The details
The algorithm identifies metastasis by analyzing five specific predictors: Breslow thickness, lymph-node short-axis diameter, contrast-enhanced ultrasound findings, vascular invasion, and PET-CT results. Researchers selected these variables using Boruta and LASSO regression techniques to ensure high diagnostic accuracy. The model uses nested cross-validation to calibrate its predictions against clinical, pathological, and imaging data.
Timeline
The findings were published on October 26, 2026.
Health Landscape
This development represents a shift toward incorporating multi-modal imaging and pathological data into predictive oncology tools. It builds on the broader trend of using machine learning to refine staging accuracy beyond traditional metrics like Breslow thickness.
Patients diagnosed with acral melanoma should speak with their oncology team about the specific diagnostic tests being used to assess their lymph nodes. Asking about the use of integrated imaging and pathology reporting can help ensure the most accurate staging possible for your condition.
The takeaway
This new predictive model may offer a more precise way to identify lymph node involvement in acral melanoma than current clinical standards. If you or a loved one are navigating a melanoma diagnosis, talk to your physician about the diagnostic techniques being used to evaluate your staging.
Further reading
For more on evolving diagnostic tools, visit our Cancer section.
More information
View the peer-reviewed research article for full methodology details.
Source note: This article includes information reported by Nature.
Live Poll
Do you trust diagnostic models developed by artificial intelligence as much as human medical experts?
